ARS Wealth Advisors’s iShares US Medical Devices ETF IHI Stock Holding History

ARS Wealth Advisors’s Portfolio IHI Stock Details IHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$650K	Hold	10,800	–	–	0.12%	70
2021 Q1	$595K	Hold	10,800	–	–	0.13%	63
2020 Q4	$589K	Buy	+10,800	New	+$565K	0.13%	63

Other funds holding IHI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

ARS Wealth Advisors's IHI Position: Q2 2021 in Review

ARS Wealth Advisors held its iShares US Medical Devices ETF (IHI) position steady in Q2 2021 at 10,800 shares worth $650K. The position accounts for 0.12% of the portfolio, ranked #70.

ARS Wealth Advisors first reported a position in IHI in Q4 2020 and has held it in 3 quarters since. 559 funds tracked by Wall St. Rank hold IHI as of Q2 2021.

ARS Wealth Advisors held 10,800 shares of iShares US Medical Devices ETF worth $650K as of Q2 2021.
ARS Wealth Advisors left its iShares US Medical Devices ETF share count unchanged in Q2 2021.
iShares US Medical Devices ETF made up 0.12% of ARS Wealth Advisors's portfolio in Q2 2021, its #70 holding.
ARS Wealth Advisors first reported a position in iShares US Medical Devices ETF in Q4 2020 and has held it in 3 quarters since.
559 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2021.

Based on ARS Wealth Advisors's 13F filing for Q2 2021, filed 15 Jul 2021.